Table of Contents
<< Previous Issue | Dec 2017 (Vol: 2017, Issue: 12) | Next Issue >> |
- Section: Licensing
-
Biogen Looks to Extend its MS Leadership Through Licensing
- Section: Mergers & Acquisitions
-
The Medicines Company Sells Infectious Disease Unit
- Section: Opinion & Analysis
-
Value for Money? An Analysis of Five Product-Driven M&A Deals
- Section: Research & Development
-
Janssen Collaborates with Idorsia on Aprocitentan